The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

16 results found.

Example of search result explained

Hyrimoz (syringe)

Exceptional medication

Active ingredient(s):

adalimumab (uveitis)
Manufactured by:

Sandoz Canada Inc (Sandoz)
Strength and dosage form:
Subcutaneous Injectable Solution 100 mg/mL (0,2 mL) DIN : 99114304

Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114305

Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114307

Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114107

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114108

Hadlima PushTouch (pen)

Exceptional medication

Active ingredient(s):

adalimumab (uveitis)
Manufactured by:

Organon Canada Inc. (Organon)
Strength and dosage form:
Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114232

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114230

Hadlima (syringe)

Exceptional medication

Active ingredient(s):

adalimumab (uveitis)
Manufactured by:

Organon Canada Inc. (Organon)
Strength and dosage form:
Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114231

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114229

Hyrimoz (pen)

Exceptional medication

Active ingredient(s):

adalimumab (uveitis)
Manufactured by:

Sandoz Canada Inc (Sandoz)
Strength and dosage form:
Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114306

Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114308

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114109

Simlandi (syringe)

Exceptional medication

Active ingredient(s):

adalimumab (uveitis)
Manufactured by:

Jamp Pharma Corporation (Jamp)
Strength and dosage form:
Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114145

Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114147

Simlandi (pen)

Exceptional medication

Active ingredient(s):

adalimumab (uveitis)
Manufactured by:

Jamp Pharma Corporation (Jamp)
Strength and dosage form:

Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114150

Yuflyma (syringe)

Exceptional medication

Active ingredient(s):

adalimumab (uveitis)
Manufactured by:

Celltrion Healthcare Canada Limited (Celltrion)
Strength and dosage form:
Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114223

Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114222

Yuflyma (pen)

Exceptional medication

Active ingredient(s):

adalimumab (uveitis)
Manufactured by:

Celltrion Healthcare Canada Limited (Celltrion)
Strength and dosage form:
Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114224

Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114221

Abrilada (syringe)

Exceptional medication

Active ingredient(s):

adalimumab (uveitis)
Manufactured by:

Pfizer Canada Inc. (Pfizer)
Strength and dosage form:
Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114206

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114208

Amgevita (syringe)

Exceptional medication

Active ingredient(s):

adalimumab (uveitis)
Manufactured by:

Amgen Canada Inc. (Amgen)
Strength and dosage form:
Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114101

Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114102

Hyrimoz (syringe)

Hadlima PushTouch (pen)

Hadlima (syringe)

Hyrimoz (pen)

Simlandi (syringe)

Simlandi (pen)

Yuflyma (syringe)

Yuflyma (pen)

Abrilada (syringe)

Amgevita (syringe)

How did we do?